BCM
Bayesian Capital Management Portfolio holdings
AUM
$633M
1-Year Return
38.33%
This Quarter Return
+10.92%
1 Year Return
+38.33%
3 Year Return
+146.47%
5 Year Return
+216.79%
10 Year Return
–
AUM
$853M
AUM Growth
-$19.3M
(-2.2%)
Cap. Flow
-$63.5M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
13.72%
Holding
1,104
New
422
Increased
110
Reduced
108
Closed
462
Top Buys
| 1 |
Netflix
NFLX
|
$14.9M |
| 2 |
Nike
NKE
|
$13.2M |
| 3 |
MongoDB
MDB
|
$9.61M |
| 4 |
Fortinet
FTNT
|
$8.82M |
| 5 |
Texas Instruments
TXN
|
$8.22M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$39.5M |
| 2 |
Accenture
ACN
|
$13.2M |
| 3 |
Ulta Beauty
ULTA
|
$11.4M |
| 4 |
Tesla
TSLA
|
$10.9M |
| 5 |
Adobe
ADBE
|
$10.6M |
Sector Composition
| 1 | Technology | 26.05% |
| 2 | Consumer Discretionary | 16.18% |
| 3 | Healthcare | 10.72% |
| 4 | Industrials | 10.26% |
| 5 | Financials | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
XPEL
XPEL
$987M
| $438K | 0.05% |
+10,100
| New | +$438K |
|
402
Phillips Edison & Co
PECO
$4.54B
| $437K | 0.05% |
+11,600
| New | +$437K |
|
403
Regal Rexnord
RRX
$9.66B
| $435K | 0.05% |
+2,622
| New | +$435K |
|
404
Boot Barn
BOOT
$5.58B
| $435K | 0.05% |
+2,600
| New | +$435K |
|
405
Adient
ADNT
$2B
| $434K | 0.05% |
+19,245
| New | +$434K |
|
406
Silicon Laboratories
SLAB
$4.45B
| $434K | 0.05% |
+3,753
| New | +$434K |
|
|
RVNC
407
DELISTED
Revance Therapeutics, Inc.
RVNC
| $433K | 0.05% |
+83,500
| New | +$433K |
|
408
Canadian Pacific Kansas City
CP
$70.3B
| $429K | 0.05% |
+5,021
| New | +$429K |
|
409
The Bancorp
TBBK
$3.49B
| $425K | 0.05% |
7,952
+1,452
| +22% | +$77.7K |
|
410
Eos Energy Enterprises
EOSE
$2.01B
| $423K | 0.05% |
+142,400
| New | +$423K |
|
411
Synaptics
SYNA
$2.7B
| $423K | 0.05% |
+5,446
| New | +$423K |
|
412
American Airlines Group
AAL
$8.63B
| $419K | 0.05% |
+37,300
| New | +$419K |
|
413
Workday
WDAY
$61.7B
| $416K | 0.05% |
+1,701
| New | +$416K |
|
414
Carpenter Technology
CRS
$12.3B
| $415K | 0.05% |
+2,600
| New | +$415K |
|
415
CRISPR Therapeutics
CRSP
$4.99B
| $413K | 0.05% |
8,800
+2,600
| +42% | +$122K |
|
416
Patterson-UTI
PTEN
$2.18B
| $412K | 0.05% |
+53,800
| New | +$412K |
|
417
IAC Inc
IAC
$2.98B
| $410K | 0.05% |
9,296
-4,876
| -34% | -$215K |
|
418
Pacira BioSciences
PCRX
$1.19B
| $408K | 0.05% |
+27,080
| New | +$408K |
|
419
Sociedad Química y Minera de Chile
SQM
$13.1B
| $404K | 0.05% |
9,700
-26,800
| -73% | -$1.12M |
|
420
IDEAYA Biosciences
IDYA
$2.38B
| $402K | 0.05% |
+12,686
| New | +$402K |
|
421
Associated Banc-Corp
ASB
$4.42B
| $402K | 0.05% |
+18,649
| New | +$402K |
|
422
Zimmer Biomet
ZBH
$20.9B
| $400K | 0.05% |
+3,707
| New | +$400K |
|
423
Travere Therapeutics
TVTX
$1.93B
| $398K | 0.05% |
+28,415
| New | +$398K |
|
424
Moderna
MRNA
$9.78B
| $394K | 0.05% |
+5,900
| New | +$394K |
|
425
SLM Corp
SLM
$6.49B
| $393K | 0.05% |
+17,200
| New | +$393K |
|